MURRAY HILL, N.J.--(BUSINESS WIRE)--June 21, 2007--C. R. Bard, Inc. (NYSE: BCR) announced today that at its June board meeting, the Board of Directors elected John A. DeFord, Ph.D., to the position of Senior Vice President, Science, Technology and Clinical Affairs, effective immediately.

Dr. DeFord joined Bard in January 2004 as Vice President, Science and Technology. Prior to joining Bard, he was a Managing Director responsible for life sciences investments with Early Stage Partners, a Cleveland, Ohio-based venture capital fund. Previously, Dr. DeFord was employed by Cook, Inc., and held a variety of senior positions, including President and Chief Executive Officer. He earned a B.S. and an M.S. degree in Electrical Engineering and a Ph.D. in Electrical/Biomedical Engineering, all from Purdue University.

C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, NJ, is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.

CONTACT: C. R. Bard, Inc.
Investor Relations:
Eric J. Shick, 908-277-8413
Vice President, Investor Relations
or
Media Relations:
Holly P. Glass, 703-754-2848
Vice President, Government and Public Relations

SOURCE: C. R. Bard, Inc.